July 10, 2014
Novartis AG has drawn up new global guidelines for investigator-initiated trials (IITs) after a string of scandals surrounding independent studies in Japan shed light on cozy relationships between its local unit and physicians. Defining IITs as clinical and non-clinical studies...read more